<Blinded Review: TIME_ANON_0316>
**Composite Score:** 9.4 / 10.0 (Rigor: 3.3/3.5 | Claims: 2.4/2.5 | Biology: 1.9/2.0 | Reproducibility: 1.8/2.0)
**Bias Category:** None (Methodologically Sound)
**Verdict:** Minor Revision
**Study Modality:** Wet-Lab Primary Experimental
**Technology Maturity:** Mature/Classical
**Epistemic Stage:** Basic/Mechanistic Discovery

---

### 1. Executive Summary
This study defines the cis-acting regulatory element and trans-acting transcription factor responsible for the synergistic transcriptional induction of inducible nitric oxide synthase (`iNOS` / *Nos2*) by interferon-gamma (`IFN-γ`) and bacterial lipopolysaccharide (`LPS`) in murine `RAW 264.7` macrophages. Through 5'-deletion mapping of `iNOS` promoter–chloramphenicol acetyltransferase (`CAT`) constructs (`-1588/+161` truncated to `-975/+161` vs. `-721/+161`), the authors localize the `IFN-γ`-responsive enhancer region to `-951` to `-911`, which contains a cluster of four putative `IFN-γ` response elements (`GAS`, `ISREu`, `ISREd`, and an antisense interferon regulatory factor binding element [`IRF-E`] at `-913` to `-923`). Introducing a 2-bp point substitution (`AA` $\rightarrow$ `GG`) into the conserved core of the `IRF-E` site within the full-length `-1588/+161` promoter—engineered into a single dual-reporter plasmid (`p1-luc` vs. `p1(IRFm)-luc`) carrying a constitutive `SV40-luciferase` cassette for internal transfection normalization—completely abolishes `IFN-γ` synergy while preserving `LPS` inducibility. Electrophoretic mobility shift assays (EMSAs), cold oligonucleotide competitions, supershift assays with purified anti-`IRF-1` vs. anti-`STAT91` antibodies, and `BrdU`-substituted UV cross-linking (`40–45 kDa` major species) demonstrate that `IFN-γ` induces a nuclear complex (`complex B`) containing `IRF-1` that binds specifically to the `-913/-923` `IRF-E` site and is abolished by the 2-bp `IRF-E` mutation.

This is a model classical molecular biology and biochemistry paper: experimental controls are exceptionally tight, claims are crisp and directly supported by orthogonal functional and biochemical assays, and potential experimental confounders are proactively addressed.

### 2. Methodological & Statistical Audit
- **Exceptional Experimental Controls:**
  - **Single-plasmid dual-reporter normalization (`p1-luc` and `p1(IRFm)-luc`):** Rather than relying on co-transfection of two separate plasmids (which can suffer from variable co-uptake or promoter competition), the authors subcloned the `SV40-luciferase` normalization cassette directly into the `BamHI` site of both the wild-type `p1iNOS-CAT` and mutant `p1(IRFm)` constructs (`Methods, page 978`), eliminating differences in plasmid prep quality or transfection efficiency across $n = 4$ independent normalized experiments (+ $n = 2$ unnormalized confirmatory experiments).
  - **Endotoxin quality control of plasmid DNA preparations:** Recognizing that picogram traces of `E. coli` LPS in plasmid preparations can desensitize macrophages to subsequent `IFN-γ` + `LPS` stimulation (`Discussion, page 981`), the authors screened all undiluted plasmid stocks using a quantitative chromogenic *Limulus* amebocyte lysate (`LAL`) assay and used only preparations contributing `<25 pg/ml` LPS at transfection concentrations.
  - **Mutational specificity in context of the full-length (`1.75 kb`) promoter:** Instead of testing isolated multimerized enhancer oligonucleotides in front of a heterologous minimal promoter, the authors introduced a precise 2-bp substitution (`AA` $\rightarrow$ `GG` at `-918/-919`) within the native `-1588/+161` `iNOS` promoter context (`Figure 1B`, `Figure 2`). Not only did this ablate `IFN-γ` synergy (`1.03 ± 0.1%` vs. `3.35 ± 1.4%` acetylation at `10 ng/ml LPS`), it also unmasked higher basal `LPS` responsiveness (`3.20 ± 1.0%` vs. `1.4 ± 0.1%` without `IFN-γ`), consistent with displacement of a constitutive repressor (such as `IRF-2` or `ICSBP` corresponding to `complex A`).
  - **Biochemical identification of `IRF-1` (`Figures 3–5`):** EMSA dissection using the 48-bp quad-element probe, split `IRF-E/ISREd` vs. `GAS/ISREu` sub-probes, and the 2-bp mutant `IRF-Em/ISREdm` probe cleanly separates constitutive complexes `A` and `C` from the `IFN-γ`-inducible `complex B` (`Figure 3A,B`). Supershift with purified rabbit anti-murine `IRF-1` IgG (tested at two dilutions, `1:10` and `1:250`, added either 60 min before or 30 min after DNA probe binding, alongside matched pre-immune IgG and anti-`STAT91` controls; `Figure 4`) and `BrdU` UV cross-linking (`40–45 kDa` band matching `IRF-1`; `Figure 5`) leave no ambiguity as to protein identity.
- **Minor Reporting Points:**
  - Quantitative `CAT` values for the intermediate 5'-deletion construct `p10.5iNOS-CAT` (`-975/+161`) and the negative `anti-STAT91` supershift are described in the text as `"data not shown"`; including the numerical mean ± SEM for `p10.5iNOS-CAT` in the text would complete the deletion series table.

### 3. Biological / Experimental Grounding & Claim Proportionality
- **Claim 1:** *"Site-specific substitution of two conserved nucleotides within IRF-E [-913 to -923] in the context of the full-length iNOS promoter ablated IFN-gamma's contribution to synergistic enhancement of transcription."* `[Well Supported]`
  - Directly demonstrated in `Figure 2` across an `LPS` dose-response curve (`0, 0.1, 1, 10 ng/ml`) with internal luciferase normalization ($n = 4$).
- **Claim 2:** *"Electromobility shift assays performed with a probe containing IRF-E revealed the existence of a complex in nuclei of RAW 264.7 macrophages that was present only after treatment with IFN-gamma, which reacted specifically with anti-IRF-1 immunoglobulin G and which included a species migrating at 40-45 kD, consistent with the apparent molecular weight of murine IRF-1."* `[Well Supported]`
  - Directly proven by `Figures 3, 4, and 5`.
- **Claim 3:** *"In conjunction with the work of Kamijo et al. [showing absence of iNOS mRNA in IRF-1-/- macrophages], these findings identify iNOS as the first gene that requires IRF-1 for IFN-gamma-dependent transcriptional regulation."* `[Well Supported]`
  - The synthesis of genetic necessity (`IRF-1-/-` mice) with direct cis-element mutagenesis (`IRF-Em`) and physical promoter binding (`IRF-1` supershift/cross-linking) is airtight, and the Discussion thoughtfully considers additional roles for `IRF-1` and downstream elements (`NF-κBd` at `-85/-76` and intervening DNA bending).

### 4. Reproducibility & Data Completeness
- **Sequence & Protocol Completeness:** Exact promoter coordinates (`-1588` to `+161`, `-973` to `-899`), complete sense and antisense sequences of all four EMSA oligonucleotide probes (`48-bp`, `IRF-E/ISREd`, `GAS/ISREu`, `IRF-Em/ISREdm`), plasmid construction steps, `LAL` endotoxin thresholds, and EMSA/UV cross-linking conditions are fully specified in the text.
</Blinded Review: TIME_ANON_0316>
